标题
The Diverse Function of PD-1/PD-L Pathway Beyond Cancer
作者
关键词
-
出版物
Frontiers in Immunology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-10-04
DOI
10.3389/fimmu.2019.02298
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- PD-1/PD-L1 Pathway Modulates Macrophage Susceptibility to Mycobacterium tuberculosis Specific CD8+ T cell Induced Death
- (2019) Guadalupe Verónica Suarez et al. Scientific Reports
- MiR-873/PD-L1 axis regulates the stemness of breast cancer cells
- (2019) Lanlan Gao et al. EBioMedicine
- Mycobacterium tuberculosis antigens repress Th1 immune response suppression and promotes lung cancer metastasis through PD-1/PDl-1 signaling pathway
- (2019) Shuhui Cao et al. Cell Death & Disease
- PD-1/PD-L Pathway Potentially Involved in ITP Immunopathogenesis
- (2019) Mu Nie et al. THROMBOSIS AND HAEMOSTASIS
- microRNA-148a-3p regulates immunosuppression in DNA mismatch repair-deficient colorectal cancer by targeting PD-L1
- (2019) Mai Ashizawa et al. MOLECULAR CANCER RESEARCH
- OX40 stimulation and PD-L1 blockade synergistically augment HBV-specific CD4 T cells in patients with HBeAg-negative infection
- (2019) Felix Johannes Jacobi et al. JOURNAL OF HEPATOLOGY
- Liver-Resident NK Cells Control Antiviral Activity of Hepatic T Cells via the PD-1-PD-L1 Axis
- (2019) Jing Zhou et al. IMMUNITY
- Checkpoint inhibitors
- (2019) Lucie Heinzerling et al. Deutsches Arzteblatt International
- PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
- (2019) Takahiro Kamada et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A PD-1-specific toxin suppresses autoimmunity
- (2019) Zhirui Wang et al. Nature Biomedical Engineering
- Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy
- (2019) Heng-Huan Lee et al. CANCER CELL
- Dysregulation of the PD-1/PD-L1 pathway contributes to the pathogenesis of celiac disease
- (2019) Candelaria Ponce de León et al. Cellular & Molecular Immunology
- Programmed Cell Death-1 Receptor (PD-1)-Mediated Regulation of Innate Lymphoid Cells
- (2019) Grace Mallett et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Analysis of the PD-1/PD-L1 axis in human autoimmune thyroid disease: Insights into pathogenesis and clues to immunotherapy associated thyroid autoimmunity
- (2019) Daniel Álvarez-Sierra et al. JOURNAL OF AUTOIMMUNITY
- Anti-PD-1 Blockade with Nivolumab with and without Therapeutic Vaccination for Virally Suppressed Chronic Hepatitis B: A Pilot Study
- (2019) Edward Gane et al. JOURNAL OF HEPATOLOGY
- TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection
- (2019) Francesca Alfei et al. NATURE
- TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8+ T cell exhaustion
- (2019) Hyungseok Seo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD4+ T cell exhaustion revealed by high PD-1 and LAG-3 expression and the loss of helper T cell function in chronic hepatitis B
- (2019) Yuejiao Dong et al. BMC IMMUNOLOGY
- Genetic Aberrations in the CDK4 Pathway Are Associated with Innate Resistance to PD-1 Blockade in Chinese Patients with Non-Cutaneous Melanoma
- (2019) Jiayi Yu et al. CLINICAL CANCER RESEARCH
- The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis
- (2019) Karthik Suresh et al. JOURNAL OF CLINICAL INVESTIGATION
- Toxicities Associated With PD-1/PD-L1 Blockade
- (2018) Daniel Y. Wang et al. CANCER JOURNAL
- Progress and challenges of predictive biomarkers of anti PD-1/PD-L1 immunotherapy: A systematic review
- (2018) Feifei Teng et al. CANCER LETTERS
- Immune checkpoint receptors: homeostatic regulators of immunity
- (2018) Antonio Riva et al. Hepatology International
- Regulation and Function of the PD-L1 Checkpoint
- (2018) Chong Sun et al. IMMUNITY
- Co-inhibitory Molecule B7 Superfamily Member 1 Expressed by Tumor-Infiltrating Myeloid Cells Induces Dysfunction of Anti-tumor CD8 + T Cells
- (2018) Jing Li et al. IMMUNITY
- PD-1/PD-L1 in disease
- (2018) Nyanbol Kuol et al. Immunotherapy
- Sepsis Induces a Dysregulated Neutrophil Phenotype That Is Associated with Increased Mortality
- (2018) Jaimin M. Patel et al. MEDIATORS OF INFLAMMATION
- Metabolic exhaustion in infection, cancer and autoimmunity
- (2018) E. F. McKinney et al. NATURE IMMUNOLOGY
- Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
- (2018) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD38-mediated immunosuppression as a mechanism of tumor cell escape from PD-1/PD-L1 blockade
- (2018) Limo Chen et al. Cancer Discovery
- PD-1 Controls Follicular T Helper Cell Positioning and Function
- (2018) Jingwen Shi et al. IMMUNITY
- PD-1/PD-L1 immune checkpoint: Potential target for cancer therapy
- (2018) Fatemeh K. Dermani et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Immunomodulators targeting the PD-1/PD-L1 protein-protein interaction: From antibodies to small molecules
- (2018) Jeffrey Yang et al. MEDICINAL RESEARCH REVIEWS
- Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
- (2018) Gang Chen et al. NATURE
- Endogenous glucocorticoids control host resistance to viral infection through the tissue-specific regulation of PD-1 expression on NK cells
- (2018) Linda Quatrini et al. NATURE IMMUNOLOGY
- Association of PD-1 and PD-L1 Genetic Polymorphyisms with Type 1 Diabetes Susceptibility
- (2018) Chenyue Qian et al. Journal of Diabetes Research
- Anti-PD-1/PD-L1 therapy for infectious diseases: learning from the cancer paradigm
- (2017) Martin Rao et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Targeting Immune Cell Checkpoints during Sepsis
- (2017) Naeem Patil et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PD-L1
- (2017) Anthousa Kythreotou et al. JOURNAL OF CLINICAL PATHOLOGY
- Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy
- (2017) Cynthia L. Gay et al. JOURNAL OF INFECTIOUS DISEASES
- Tonsil-derived mesenchymal stem cells (T-MSCs) prevent Th17-mediated autoimmune response via regulation of the programmed death-1/programmed death ligand-1 (PD-1/PD-L1) pathway
- (2017) Ji-Yon Kim et al. Journal of Tissue Engineering and Regenerative Medicine
- Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)
- (2017) Jacob Schachter et al. LANCET
- Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
- (2017) Riccardo Mezzadra et al. NATURE
- PD-L1 inhibits acute and chronic pain by suppressing nociceptive neuron activity via PD-1
- (2017) Gang Chen et al. NATURE NEUROSCIENCE
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2017) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Affinity purification mass spectrometry analysis of PD-1 uncovers SAP as a new checkpoint inhibitor
- (2017) Michael Peled et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition
- (2017) Enfu Hui et al. SCIENCE
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- In vivo imaging reveals a tumor-associated macrophage–mediated resistance pathway in anti–PD-1 therapy
- (2017) Sean P. Arlauckas et al. Science Translational Medicine
- PD-1 checkpoint inhibition: Toxicities and management
- (2017) Andrew W. Hahn et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Cancer therapies in HIV cure research
- (2017) Thomas A. Rasmussen et al. Current Opinion in HIV and AIDS
- Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape
- (2017) Takuro Noguchi et al. Cancer Immunology Research
- Structural basis of a novel PD-L1 nanobody for immune checkpoint blockade
- (2017) Fei Zhang et al. Cell Discovery
- Antibody-Mediated Thyroid Dysfunction During T-cell Checkpoint Blockade in Patients with Non-Small Cell Lung Cancer
- (2016) J.C. Osorio et al. ANNALS OF ONCOLOGY
- Management of toxicities of immune checkpoint inhibitors
- (2016) Lavinia Spain et al. CANCER TREATMENT REVIEWS
- Dermatologic complications of anti-PD-1/PD-L1 immune checkpoint antibodies
- (2016) Vincent Sibaud et al. CURRENT OPINION IN ONCOLOGY
- Programmed Death-1 Ligand 2-Mediated Regulation of the PD-L1 to PD-1 Axis Is Essential for Establishing CD4 + T Cell Immunity
- (2016) Deshapriya S. Karunarathne et al. IMMUNITY
- PD-1/PD-L1 blockage in cancer treatment—from basic research to clinical application
- (2016) Masaki Mandai International Journal of Clinical Oncology
- Inflammation Perturbs the IL-7 Axis, Promoting Senescence and Exhaustion that Broadly Characterize Immune Failure in Treated HIV Infection
- (2016) Carey L. Shive et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1–high T cells
- (2016) Jong Hoon Kim et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Sepsis-induced immune dysfunction: can immune therapies reduce mortality?
- (2016) Matthew J. Delano et al. JOURNAL OF CLINICAL INVESTIGATION
- Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1
- (2016) Andriani C. Patera et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors
- (2016) Frank B. Cortazar et al. KIDNEY INTERNATIONAL
- Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study
- (2016) Corey J Langer et al. LANCET ONCOLOGY
- Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers
- (2016) Keisuke Kataoka et al. NATURE
- Follicular CXCR5-expressing CD8+ T cells curtail chronic viral infection
- (2016) Ran He et al. NATURE
- Single-cell RNA-seq identifies a PD-1hi ILC progenitor and defines its development pathway
- (2016) Yong Yu et al. NATURE
- Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy
- (2016) Se Jin Im et al. NATURE
- Immune checkpoints and rheumatic diseases: what can cancer immunotherapy teach us?
- (2016) Michiel van der Vlist et al. Nature Reviews Rheumatology
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade
- (2016) Douglas B. Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade
- (2016) K. E. Pauken et al. SCIENCE
- Structure and Dynamics of PD-L1 and an Ultra-High-Affinity PD-1 Receptor Mutant
- (2016) Roberta Pascolutti et al. STRUCTURE
- Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection
- (2016) Matthias Hoffmann et al. PLoS Pathogens
- TGFβ-dependent expression of PD-1 and PD-L1 controls CD8+ T cell anergy in transplant tolerance
- (2016) Marije Baas et al. eLife
- Role of T‐Cell Dysfunction, Inflammation, and Coagulation in Microvascular Disease in HIV
- (2016) Arjun Sinha et al. Journal of the American Heart Association
- Up-regulation of Programmed Cell Death 1 Ligand 1 on Neutrophils May Be Involved in Sepsis-induced Immunosuppression
- (2015) Jia-Feng Wang et al. ANESTHESIOLOGY
- Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies
- (2015) J. Naidoo et al. ANNALS OF ONCOLOGY
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Low programmed cell death-1 (PD-1) expression in peripheral CD4+T cells in Japanese patients with autoimmune type 1 diabetes
- (2015) R. Fujisawa et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8+T cells
- (2015) Pamela M. Odorizzi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Clinical Relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 Network in Chemoresistant Non-small-cell Lung Cancer
- (2015) Yu Fujita et al. MOLECULAR THERAPY
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- New immunotherapies targeting the PD-1 pathway
- (2015) Jordan M. Chinai et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Soluble PD-1 aggravates progression of collagen-induced arthritis through Th1 and Th17 pathways
- (2015) Cuiping Liu et al. ARTHRITIS RESEARCH & THERAPY
- Immunological biomarkers predict HIV-1 viral rebound after treatment interruption
- (2015) Jacob Hurst et al. Nature Communications
- Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer
- (2015) Jiabei He et al. Scientific Reports
- IL-12 Regulates B7-H1 Expression in Ovarian Cancer-associated Macrophages by Effects on NF-κB Signalling
- (2014) Hai-Yu Xiong et al. Asian Pacific Journal of Cancer Prevention
- The PD-1/PD-Ls pathway and autoimmune diseases
- (2014) Suya Dai et al. CELLULAR IMMUNOLOGY
- PD-L1 gene polymorphisms and low serum level of PD-L1 protein are associated to type 1 diabetes in Chile
- (2014) Carolina Pizarro et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Protective effects of Fc-fused PD-L1 on two different animal models of colitis
- (2014) Mi-Young Song et al. GUT
- MiR-20b, -21, and -130b inhibit PTEN expression resulting in B7-H1 over-expression in advanced colorectal cancer
- (2014) Jianjie Zhu et al. HUMAN IMMUNOLOGY
- The Transcription Factor FoxO1 Sustains Expression of the Inhibitory Receptor PD-1 and Survival of Antiviral CD8+ T Cells during Chronic Infection
- (2014) Matthew M. Staron et al. IMMUNITY
- Cross-Linking of B7-H1 on EBV-Transformed B Cells Induces Apoptosis through Reactive Oxygen Species Production, JNK Signaling Activation, and fasL Expression
- (2014) Y. S. Kim et al. JOURNAL OF IMMUNOLOGY
- The Common -Chain Cytokines IL-2, IL-7, IL-15, and IL-21 Induce the Expression of Programmed Death-1 and Its Ligands
- (2014) A. L. Kinter et al. JOURNAL OF IMMUNOLOGY
- Both PD-1 Ligands Protect the Kidney from Ischemia Reperfusion Injury
- (2014) Katarzyna Jaworska et al. JOURNAL OF IMMUNOLOGY
- Active players in resolution of shock/sepsis induced indirect lung injury: immunomodulatory effects of Tregs and PD-1
- (2014) Lunxian Tang et al. JOURNAL OF LEUKOCYTE BIOLOGY
- FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS
- (2014) Yawei Liu et al. NATURE MEDICINE
- Essential Role of Program Death 1-Ligand 1 in Regulatory T-Cell–Afforded Protection Against Blood–Brain Barrier Damage After Stroke
- (2014) Peiying Li et al. STROKE
- Regulation of Neuroinflammation through Programed Death-1/Programed Death Ligand Signaling in Neurological Disorders
- (2014) Shangfeng Zhao et al. Frontiers in Cellular Neuroscience
- Tissue-Expressed B7-H1 Critically Controls Intestinal Inflammation
- (2014) Lisa Scandiuzzi et al. Cell Reports
- Immune Modulation in Cancer with Antibodies
- (2013) David B. Page et al. Annual Review of Medicine
- Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity
- (2013) Elena Gianchecchi et al. AUTOIMMUNITY REVIEWS
- PD-1, but Not PD-L1, Expressed by Islet-Reactive CD4 + T Cells Suppresses Infiltration of the Pancreas During Type 1 Diabetes
- (2013) Kristen E. Pauken et al. DIABETES
- Blockade of Programmed Death-1 in Young (New Zealand Black x New Zealand White)F1 Mice Promotes the Suppressive Capacity of CD4+ Regulatory T Cells Protecting from Lupus-like Disease
- (2013) M. Wong et al. JOURNAL OF IMMUNOLOGY
- Identification of B7-H1 as a Novel Mediator of the Innate Immune/Proinflammatory Response as well as a Possible Myeloid Cell Prognostic Biomarker in Sepsis
- (2013) X. Huang et al. JOURNAL OF IMMUNOLOGY
- PD-L1 enhances CNS inflammation and infarct volume following experimental stroke in mice in opposition to PD-1
- (2013) Sheetal Bodhankar et al. Journal of Neuroinflammation
- Highly Pathological Influenza A Virus Infection Is Associated with Augmented Expression of PD-1 by Functionally Compromised Virus-Specific CD8+ T Cells
- (2013) J. A. Rutigliano et al. JOURNAL OF VIROLOGY
- PD-L1 Blockade Attenuated Sepsis-Induced Liver Injury in a Mouse Cecal Ligation and Puncture Model
- (2013) Weimin Zhu et al. MEDIATORS OF INFLAMMATION
- PD-1 Increases PTEN Phosphatase Activity While Decreasing PTEN Protein Stability by Inhibiting Casein Kinase 2
- (2013) Nikolaos Patsoukis et al. MOLECULAR AND CELLULAR BIOLOGY
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lack of PD-L1 Expression by iNKT Cells Improves the Course of Influenza A Infection
- (2013) Hadi Maazi et al. PLoS One
- A Potential New Pathway for PD-L1 Costimulation of the CD8-T Cell Response to Listeria monocytogenes Infection
- (2013) Daqi Xu et al. PLoS One
- A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus Infection
- (2013) David Gardiner et al. PLoS One
- Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
- (2013) M. J. Fuller et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The changing immune system in sepsis
- (2013) Jonathan S Boomer et al. Virulence
- The putative role of endoplasmic reticulum aminopeptidases in autoimmunity: Insights from genomic-wide association studies
- (2012) Alessandra Fierabracci et al. AUTOIMMUNITY REVIEWS
- Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice
- (2012) Helge Frebel et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2
- (2012) Tadashi Yokosuka et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Progenitor and Terminal Subsets of CD8+ T Cells Cooperate to Contain Chronic Viral Infection
- (2012) M. A. Paley et al. SCIENCE
- TNF-α and TGF-β Counter-Regulate PD-L1 Expression on Monocytes in Systemic Lupus Erythematosus
- (2012) Jing-Ni Ou et al. Scientific Reports
- The CTLA-4 and PD-1/PD-L1 Inhibitory Pathways Independently Regulate Host Resistance to Plasmodium-induced Acute Immune Pathology
- (2012) Julius Clemence R. Hafalla et al. PLoS Pathogens
- Are autoimmune diseases predictable?
- (2011) Gabriel J. Tobón et al. AUTOIMMUNITY REVIEWS
- Development of a sandwich ELISA for evaluating soluble PD-L1 (CD274) in human sera of different ages as well as supernatants of PD-L1+ cell lines
- (2011) Yongjing Chen et al. CYTOKINE
- Chronic Virus Infection Enforces Demethylation of the Locus that Encodes PD-1 in Antigen-Specific CD8+ T Cells
- (2011) Ben Youngblood et al. IMMUNITY
- Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
- (2011) Jonathan S. Boomer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- IFN- Directly Promotes Programmed Cell Death-1 Transcription and Limits the Duration of T Cell-Mediated Immunity
- (2011) S. Terawaki et al. JOURNAL OF IMMUNOLOGY
- Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection
- (2011) Noah S Butler et al. NATURE IMMUNOLOGY
- A potential role for the PD1/PD-L1 pathway in the neuroinflammation of Alzheimer's disease
- (2011) Marina Saresella et al. NEUROBIOLOGY OF AGING
- T Cells from Programmed Death-1 Deficient Mice Respond Poorly to Mycobacterium tuberculosis Infection
- (2011) Sultan Tousif et al. PLoS One
- Programmed Death-1 Pathway Limits Central Nervous System Inflammation and Neurologic Deficits in Murine Experimental Stroke
- (2011) Xuefang Ren et al. STROKE
- The inhibitory pathway PD-1/PD-1 ligands is upregulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis
- (2010) Amalia P. Raptopoulou et al. ARTHRITIS AND RHEUMATISM
- Programmed death-1/B7-H1 negative costimulation protects mouse liver against ischemia and reperfusion injury
- (2010) Haofeng Ji et al. HEPATOLOGY
- The PD-1 pathway in tolerance and autoimmunity
- (2010) Loise M. Francisco et al. IMMUNOLOGICAL REVIEWS
- Defining and analyzing geoepidemiology and human autoimmunity
- (2010) Yinon Shapira et al. JOURNAL OF AUTOIMMUNITY
- Acute depletion of activated memory B cells involves the PD-1 pathway in rapidly progressing SIV-infected macaques
- (2010) Kehmia Titanji et al. JOURNAL OF CLINICAL INVESTIGATION
- CD4 T Cells Promote Rather than Control Tuberculosis in the Absence of PD-1-Mediated Inhibition
- (2010) D. L. Barber et al. JOURNAL OF IMMUNOLOGY
- PD-L1hi retinal pigment epithelium (RPE) cells elicited by inflammatory cytokines induce regulatory activity in uveitogenic T cells
- (2010) Yan Ke et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis
- (2010) P. Brahmamdam et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus
- (2009) George K. Bertsias et al. ARTHRITIS AND RHEUMATISM
- PD-1 on dendritic cells impedes innate immunity against bacterial infection
- (2009) S. Yao et al. BLOOD
- Costimulatory Pathways in Multiple Sclerosis: Distinctive Expression of PD-1 and PD-L1 in Patients with Different Patterns of Disease
- (2009) D. Trabattoni et al. JOURNAL OF IMMUNOLOGY
- Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9
- (2009) Maya Koronyo-Hamaoui et al. JOURNAL OF NEUROCHEMISTRY
- PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis
- (2009) X. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells
- (2008) T. Azuma et al. BLOOD
- Enhancing SIV-specific immunity in vivo by PD-1 blockade
- (2008) Vijayakumar Velu et al. NATURE
- The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors
- (2008) D. Y.-w. Lin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective expansion of a subset of exhausted CD8 T cells by PD-L1 blockade
- (2008) S. D. Blackburn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started